Boone Elke, Verhaaf Brenda, Langerak Anton W
Heilig Hart Ziekenhuis, Roeselare, Belgium.
Methods Mol Biol. 2013;971:65-91. doi: 10.1007/978-1-62703-269-8_4.
The assessment of the presence of clonal lymphoproliferations via polymerase chain reaction (PCR)-based analysis of rearranged immunoglobulin (Ig) or T-cell receptor (TCR) genes is a valuable technique in the diagnosis of suspect lymphoproliferative disorders. Furthermore this technique is more and more used to evaluate dissemination of non-Hodgkin lymphoma and/or the presence of (minimal) residual disease. In this chapter we describe an integrated approach to assess clonality via analysis of Ig heavy chain (IGH), Ig kappa (IGK), TCR beta (TCRB), and TCR gamma (TCRG) gene rearrangements. The described PCR protocol is based on the standardized multiplex PCRs as developed by the European BIOMED-2 collaborative study (Concerted Action BMH4-CT98-3936). Furthermore it also includes the pre-analytical DNA isolation step from various tissues (formalin fixed paraffin-embedded tissue, fresh tissues, body fluids, peripheral blood and bone marrow), GeneScan analysis of labeled PCR products on a genetic analyzer, heteroduplex analysis of unlabeled PCR products, and post-analytical guidelines for the interpretation of the obtained "molecular morphology" patterns.
通过基于聚合酶链反应(PCR)的重排免疫球蛋白(Ig)或T细胞受体(TCR)基因分析来评估克隆性淋巴细胞增殖,是诊断可疑淋巴细胞增殖性疾病的一项有价值的技术。此外,该技术越来越多地用于评估非霍奇金淋巴瘤的播散和/或(微小)残留疾病的存在。在本章中,我们描述了一种通过分析Ig重链(IGH)、Igκ链(IGK)、TCRβ链(TCRB)和TCRγ链(TCRG)基因重排来评估克隆性的综合方法。所描述的PCR方案基于欧洲BIOMED-2合作研究(协同行动BMH4-CT98-3936)开发的标准化多重PCR。此外,它还包括从各种组织(福尔马林固定石蜡包埋组织、新鲜组织、体液、外周血和骨髓)中进行分析前DNA分离步骤、在基因分析仪上对标记PCR产物进行基因扫描分析、对未标记PCR产物进行异源双链分析以及对获得的“分子形态”模式进行分析后解释的指导原则。